Aventyn, Inc.

Quick facts

Phase 2 pipeline

• Coromec Registry with ECL-19
  Coromec Registry with ECL-19 is a small molecule that targets the molecular target.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Aventyn, Inc. portfolio CI brief
• Aventyn, Inc. pipeline updates RSS